ホーム › 卵巣がん › ウィスコンシン

ウィスコンシンにおける卵巣がんの臨床試験

ウィスコンシン内の拠点で、卵巣がんに関する29件の研究が参加者を募集しています。

ウィスコンシン内の都市

公式研究テキスト（英語）

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

ThedaCare Regional Cancer Center, Appleton
ThedaCare Regional Medical Center - Appleton, Appleton
Duluth Clinic Ashland, Ashland
他42件

被験者募集中第2相

全年齢 · 全性別 · 2026/10/02更新 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Wisconsin Carbone Cancer Center, Madison

被験者募集中第1/2相

12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

UW Health Carbone Cancer Center, Madison

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Milwaukee

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/29更新 · NCT05877599

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Mayo Clinic Health System - Northwest Wisconsin, Eau Claire
Mayo Clinic Health System - Southwest Wisconsin, La Crosse

被験者募集中観察研究

18歳以上 · 女性 · 2026/09/29更新 · NCT05051722

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Madison

被験者募集中第2相

18歳〜130歳 · 全性別 · 2026/09/23更新 · NCT05489211

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

University of Wisconsin Carbone Cancer Center - University Hospital, Madison

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

University of Wisconsin - Carbone Cancer Center, Madison

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Froedtert & MCW Cancer Center, Milwaukee

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/17更新 · NCT07109726

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

Froedtert and The Medical College of Wisconsin, Milwaukee

被験者募集中第3相

18歳以上 · 女性 · 2026/09/15更新 · NCT06915025

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Froedtert & the Medical College of Wisconsin, Milwaukee

被験者募集中第2相

18歳〜99歳 · 女性 · 2026/09/15更新 · NCT07023627

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Prohealth Care, Waukesha

被験者募集中第3相

18歳以上 · 女性 · 2026/09/15更新 · NCT07214779

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

University of Wisconsin, Madison
Medical College of Wisconsin, Milwaukee

被験者募集中第2相

18歳以上 · 女性 · 2026/09/14更新 · NCT06787612

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

ThedaCare Regional Cancer Center, Appleton

被験者募集中観察研究

18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444

The Vanguard Study: Testing a New Way to Screen for Cancer

Zablocki Veterans Administration Medical Center, Milwaukee

被験者募集中健康なボランティア歓迎

45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898

Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

ProHealth Care Inc, Waukesha

被験者募集中第3相

18歳以上 · 女性 · 2026/09/01更新 · NCT07564141

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee

被験者募集中第1相

18歳以上 · 全性別 · 2026/08/27更新 · NCT06582017

Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers

UW Carbone Cancer Center, Madison

被験者募集中観察研究

18歳以上 · 女性 · 2026/08/27更新 · NCT07125209

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Marshfield Medical Center-Marshfield, Marshfield
他6件

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/08/19更新 · NCT07001748

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Aurora Cancer Care-Southern Lakes VLCC, Burlington
Aurora Saint Luke's South Shore, Cudahy
Aurora Health Care Germantown Health Center, Germantown
他20件

被験者募集中

35歳〜50歳 · 女性 · 2026/08/07更新 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Duluth Clinic Ashland, Ashland
Northwest Wisconsin Cancer Center, Ashland
Aurora Cancer Care-Southern Lakes VLCC, Burlington
他33件

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Froedtert and the Medical College of Wisconsin, Milwaukee

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/07/28更新 · NCT06161025

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

121, Milwaukee

被験者募集中第2相

18歳以上 · 女性 · 2026/07/16更新 · NCT06906341

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

University of Wisconsin - Carbone Cancer Center - University Hospital, Madison

被験者募集中第2相

18歳〜100歳 · 女性 · 2026/07/13更新 · NCT05887609

Lead-212 PSV359 Therapy for Patients With Solid Tumors

University of Wisconsin, Madison

被験者募集中第1/2相

18歳〜90歳 · 全性別 · 2026/07/06更新 · NCT06710756

Integrated Cancer Repository for Cancer Research

Bellin Memorial Hospital, Green Bay

被験者募集中観察研究健康なボランティア歓迎

19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

University of Wisconsin Carbone Cancer Center, Madison

被験者募集中第1相

18歳以上 · 全性別 · 2026/06/24更新 · NCT05568680

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Froedtert Memorial Lutheran Hospital & Medical College of Wisconsin, Milwaukee

被験者募集中第3相

18歳以上 · 女性 · 2026/04/16更新 · NCT05659381

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Milwaukee

被験者募集中観察研究

全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。